Factors Responsible for Glucose Intolerance in Japanese Subjects with Impaired Fasting Glucose

Abstract

Impaired fasting glucose (IFG) represents risk of development of diabetes (DM) and its complications. We investigated insulin secretion and insulin sensitivity in 403 IFG subjects divided into three levels of 2-hour postchallenge glucose (2-h PG) to clarify the factors responsible in the development of glucose intolerance in Japanese IFG. Nearly 60% of the subjects at annual medical check-up with FPG of 6.1-7.0 mmol/l at the first screening were diagnosed by 75 g oral glucose tolerance test (OGTT) to have impaired glucose tolerance (IGT; FPG <7.0 mmol/l and 7.8 mmol/l <2-h PG <11.1 mmol/l) or DM (isolated postchallenge hyperglycemia (IPH); FPG <7.0 mmol/l and 11.1 mmol/l <2-h PG level). The primary factor in the decreased glucose tolerance was a decrease in early-phase insulin, with some contribution of increasing insulin resistance. In addition, IFG/IGT and IFG/IPH subjects showed a compensatory increase in basal insulin secretion sufficient to keep FPG levels within the non-diabetic range. IFG is composed of three different categories in basal, early-phase insulin secretion, and insulin sensitivity.

impaired fasting glucose - impaired glucose tolerance - insulin secretion - insulin sensitivity - insulinogenic index

References

• 1 Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.  Diabetes Care. 1999;  22 920-924
• 2 Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.  Lancet. 1980;  1 1373-1376
• 3 Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis.  Diabet Med. 1999;  16 212-218
• 4 Eguchi H, Kato T, Tominaga M. Significance of IGT and impaired fasting glucose on the risk of development of diabetes. The Funagata Diabetes Study.  Diabetes (Japan). 1998;  41 A107-A109
• 5 Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.  Diabetes. 2004;  53 1782-1789
• 6 Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.  Diabetes. 2003;  52 1475-1484
• 7 Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkanen L, Karter AJ, Hamman R, Saad MF. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.  Diabetes. 1997;  46 63-69
• 8 Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K. Pathogenic factors responsible for glucose intolerance in patients with NIDDM.  Diabetes. 1992;  41 1540-1546
• 9 Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis.  Metabolism. 1993;  42 1164-1168
• 10 Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, Imura H, Suzuki M, Tokuyama K. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis.  Diabetes. 1994;  43 1211-1217
• 11 Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.  Diabetes Care. 2003;  26 1211-1215
• 12 Nishi Y, Fukushima M, Suzuki H, Mitsui R, Ueda N, Taniguchi A, Nakai Y, Kawakita T, Kurose T, Seino Y, Yamada Y. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia.  Diabetes Res Clin Pract. 2005;  70 46-52
• 13 Mitsui R, Fukushima M, Nishi Y, Ueda N, Suzuki H, Taniguchi A, Nakai Y, Kawakita T, Kurose T, Yamada Y, Inagaki N, Seino Y. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men.  Metabolism. 2006;  55 53-58
• 14 Report of the Expert Committee on the Diagnosis . Classification of Diabetes Mellitus.  Diabetes Care. 1997;  20 1183-1197
• 15 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 16 Fukushima M, Taniguchi A, Sakai M, Doi K, Nagasaka S, Tanaka H, Tokuyama K, Nakai Y. Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis.  Diabetes Care. 1999;  22 1911-1912
• 17 Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.  Diabetes Care. 2001;  24 362-365
• 18 Seltzer HS, Allen EW, Herron Jr AL, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.  J Clin Invest. 1967;  46 323-335
• 19 Seino Y, Ikeda M, Yawata M, Imura H. The insulinogenic index in secondary diabetes.  Horm Metab Res. 1975;  107-115
• 20 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.  Diabetes Care. 1999;  22 1462-1470
• 21 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance . National Diabetes Data Group.  Diabetes. 1979;  28 1039-1057
• 22 Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.  Diabet Med. 1998;  15 539-553
• 23 Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.  Diabetes Care. 2000;  23 1766-1769
• 24 Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program.  Diabetes Care. 1998;  21 2191-2192
• 25 Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.  Diabetes Care. 1997;  20 1859-1862
• 26 Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez-Jauregui J, Guillen-Pineda LE, Rull JA. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.  Diabetes Care. 1998;  21 1886-1888
• 27 Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Carstensen B, Tajima N, Iwamoto Y, Borch-Johnsen K, Borch-Jonsen K. The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype.  Diabetes Res Clin Pract. 2002;  55 35-43
• 28 Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.  Diabetes. 1995;  44 1386-1391
• 29 Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.  Diabetologia. 2000;  43 1476-1483
• 30 Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.  Diabetes. 2000;  49 975-980
• 31 Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, Ohnuma H, Sugiyama K, Manaka H, Sasaki H, Fukuyama H. et al . Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan.  Diabetes Care. 1993;  16 570-574
• 32 Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawa A. et al . The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study.  Diabetologia. 1994;  37 897-904
• 33 Kosaka K, Kuzuya T, Yoshinaga H, Hagura R. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity.  Diabet Med. 1996;  13 S120-S126
• 34 Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, Tajima N. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts.  Diabetologia. 2000;  43 1470-1475
• 35 Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease.  Acta Diabetol Lat. 1975;  12 89-99
• 36 Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.  Metabolism. 2000;  49 1001-1005
• 37 Kuroe A, Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yasuda K, Yamada Y, Seino Y. Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance.  Diabetes Res Clin Pract. 2003;  59 71-77
• 38 Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.  Horm Metab Res. 2006;  38 178-182

Correspondence